Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2011
10/25/2011CA2395499C Chlamydia antigens and corresponding dna fragments and uses thereof
10/20/2011WO2011130544A2 Monitoring a dynamic system by liquid chromatography-mass spectrometry
10/20/2011WO2011130305A2 Method for displaying antibodies
10/20/2011WO2011129462A2 A YEAST EXTRACT CONTAINING γ-Glu-X OR γ-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME
10/20/2011WO2011129379A1 Novel anti-hsp90 monoclonal antibody
10/20/2011WO2011128377A1 Method for the selection of a long-term producing cell
10/20/2011WO2010076361A8 Inclusion bodies, bacterial cells and compositions containing them and uses thereof
10/20/2011US20110258710 Methods of Modifying Eukaryotic Cells
10/20/2011US20110257373 Ligands that have binding specificity for dc-sign
10/20/2011US20110257083 Msp-1 protein preparations from plasmodium
10/20/2011US20110257027 Gamma-secretase substrate and methods of use
10/20/2011US20110256620 Nucleic acid encoding a self-assembling split-fluorescent protein system
10/20/2011US20110256587 High affinity human antibodies to human nerve growth factor
10/20/2011US20110256586 Methods and Compositions for the Prevention and Treatment of Anemia
10/20/2011US20110256571 Proteins
10/20/2011US20110256533 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
10/20/2011US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site
10/20/2011US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
10/20/2011US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011US20110256154 Anti-erbb3 antibodies
10/20/2011US20110256153 CD37-Binding Molecules and Immunoconjugates Thereof
10/20/2011US20110256151 Antibodies to human il-1beta
10/20/2011US20110256145 Connective Tissue Growth Factor-3 (CTGF-3)
10/20/2011US20110256138 Amyloid-beta binding proteins
10/20/2011US20110256137 Pharmaceutical composition comprising a bispecific antibody for epcam
10/20/2011US20110256133 Anti-polyubiquitin antibodies and methods of use
10/20/2011US20110256132 Myostatin binding proteins
10/20/2011US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011US20110256056 Monoclonal Antibodies Against HER2 Antigens, and Uses Therefor
10/20/2011CA2792896A1 Method for the selection of a long-term producing cell
10/19/2011EP2378288A1 Unnatural reactive amino acid genetic code additions
10/19/2011EP2377946A1 Inclusion bodies, bacterial cells and compositions containing them and uses thereof
10/19/2011EP2377943A2 Integrated bio-product production facility and methods related thereto
10/19/2011EP2377932A1 ANTI-Siglec-15 ANTIBODY
10/19/2011EP2377891A1 Diagnosis and treatment of cancer using anti-lgr7 antibody
10/19/2011EP2376654A2 Vaccines targeting cellular death receptors
10/19/2011EP2376647A1 Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system
10/19/2011EP1930346B1 Antibody produced using ostrich and method for production thereof
10/19/2011EP1924601B1 Expression of proteins in e.coli
10/19/2011EP1762610B1 Truncated dance, dance complex and method of using these
10/19/2011EP1668136B1 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
10/19/2011EP1451338B1 Recombinant antibodies for the detection and neutralization of anthrax toxin
10/19/2011CN1973037B Process for producing dipeptides or dipeptide derivatives
10/19/2011CN1867669B Method for producing gamma-carboxylated proteins
10/19/2011CN102224244A Gene sensitive to normal-tension glaucoma disease, and use thereof
10/19/2011CN102224242A Novel gene cluster
10/19/2011CN102224238A Non-natural amino acid replication-dependent microorganisms and vaccines
10/19/2011CN102221586A Preparation method of membrane protein polypeptides for improving detection rate of membrane proteins
10/19/2011CN102220402A Method for extracting antibacterial peptide from pearl oyster meat
10/19/2011CN102220401A Method for preparing high quality fish skin collagen peptide
10/19/2011CN102220400A Method for synthesis of glutathione in vitro
10/19/2011CN102220367A Method for increasing yield of antibacterial peptide of bacillus subtilis through overexpression of yerP gene
10/19/2011CN102220366A Method for increasing yield of Bacillus subtilis antimicrobial peptide by overexpression comA gene
10/19/2011CN102220345A Recombinant canine alpha-interferon optimized gene, strain and efficient expression
10/19/2011CN102220241A Cultivated fresh water microalgae and application thereof in production of biodiesel and nervonic acid
10/19/2011CN102219830A Oxidation resisting polypeptide and preparation method thereof
10/19/2011CN102219829A Antioxidant polypeptide prepared by enzymatic hydrolysis of sharkskin collagen with acid protease
10/19/2011CN102219828A Antioxidation polypeptide prepared from sharkskin collagen
10/19/2011CN101775387B Mesoporous titanium dioxide immobilized enzyme and preparation method and application thereof
10/19/2011CN101643767B Method for preparing almond peptide from almond dregs
10/18/2011US8039607 Probe, probe set, probe carrier, and testing method
10/18/2011US8039600 Monoclonal antibodies
10/18/2011US8039599 Rapamycin assay
10/18/2011US8039597 Antibodies and related molecules that bind to 24P4C12 proteins
10/18/2011US8039596 Alpha 5-beta 1 antibodies and their uses
10/18/2011US8039595 Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation
10/18/2011US8039594 Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses
10/18/2011US8039592 Optimized Fc variants and methods for their generation
10/18/2011US8039587 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector
10/18/2011US8039586 Cerebral organic anion transporter and its gene
10/18/2011US8039257 Pre-transplant accomodated organs resistant to anti-donor immunity
10/18/2011US8039241 Thermostable alpha-amylases
10/18/2011US8039236 Process for producing dipeptides
10/18/2011US8039232 Method for producing a dipeptide
10/18/2011US8039231 Methods for enhanced production of bone morphogenetic proteins
10/18/2011US8039230 Selection of host cells expressing protein at high levels
10/18/2011US8039226 Anti NC1 monoclonal antibody
10/18/2011US8039005 Mutant forms of streptolysin O
10/18/2011CA2506329C Candida kefyr cytosine deaminase
10/18/2011CA2465156C Il-21 antagonists
10/18/2011CA2463905C Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
10/18/2011CA2328515C Continuous in-vitro evolution
10/18/2011CA2323572C Vertebrate patched-2 protein
10/18/2011CA2252986C Process for preparing functional recombinant tissue factor
10/18/2011CA2232237C Reagents and methods useful for detecting diseases of the breast
10/18/2011CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
10/13/2011WO2011127380A2 Compositions and methods for the prevention of cancer in high risk patients
10/13/2011WO2011127322A1 High mannose glycans
10/13/2011WO2011126238A2 Aboveground organ specific promoters for transforming plants and uses thereof
10/13/2011WO2011125875A1 Novel monoclonal antibody and method for immunoassaying d dimer
10/13/2011WO2011084808A3 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
10/13/2011WO2010099394A9 Alteration and modulation of protein activity by varying post-translational modification
10/13/2011US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content
10/13/2011US20110252487 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
10/13/2011US20110251376 Mammalian Tumor Susceptibility Genes and their Uses
10/13/2011US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011US20110251108 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/13/2011US20110250704 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
10/13/2011US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/13/2011US20110250644 Feed supplement for mammalian cell culture and methods of use